nodes	percent_of_prediction	percent_of_DWPC	metapath
Almotriptan—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0288	0.0389	CbGbCtD
Almotriptan—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0284	0.0384	CbGbCtD
Almotriptan—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0284	0.0384	CbGbCtD
Almotriptan—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.028	0.0379	CbGbCtD
Almotriptan—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0264	0.0356	CbGbCtD
Almotriptan—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0259	0.0349	CbGbCtD
Almotriptan—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0243	0.0328	CbGbCtD
Almotriptan—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0243	0.0328	CbGbCtD
Almotriptan—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0238	0.0322	CbGbCtD
Almotriptan—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0238	0.0322	CbGbCtD
Almotriptan—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.022	0.0297	CbGbCtD
Almotriptan—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0215	0.0291	CbGbCtD
Almotriptan—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0215	0.0291	CbGbCtD
Almotriptan—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0213	0.0288	CbGbCtD
Almotriptan—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0207	0.0279	CbGbCtD
Almotriptan—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0206	0.0278	CbGbCtD
Almotriptan—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.02	0.0271	CbGbCtD
Almotriptan—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.02	0.0271	CbGbCtD
Almotriptan—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.02	0.027	CbGbCtD
Almotriptan—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0184	0.0249	CbGbCtD
Almotriptan—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0181	0.0245	CbGbCtD
Almotriptan—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0181	0.0245	CbGbCtD
Almotriptan—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0181	0.0244	CbGbCtD
Almotriptan—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0181	0.0244	CbGbCtD
Almotriptan—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0173	0.0234	CbGbCtD
Almotriptan—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0167	0.0225	CbGbCtD
Almotriptan—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0157	0.0211	CbGbCtD
Almotriptan—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0152	0.0205	CbGbCtD
Almotriptan—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0137	0.0186	CbGbCtD
Almotriptan—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0137	0.0186	CbGbCtD
Almotriptan—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0136	0.0183	CbGbCtD
Almotriptan—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0127	0.0172	CbGbCtD
Almotriptan—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0127	0.0172	CbGbCtD
Almotriptan—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0115	0.0156	CbGbCtD
Almotriptan—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0115	0.0156	CbGbCtD
Almotriptan—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00995	0.0134	CbGbCtD
Almotriptan—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00966	0.013	CbGbCtD
Almotriptan—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00874	0.0118	CbGbCtD
Almotriptan—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00874	0.0118	CbGbCtD
Almotriptan—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00838	0.0113	CbGbCtD
Almotriptan—MAOA—nerve—acquired immunodeficiency syndrome	0.00189	0.0564	CbGeAlD
Almotriptan—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.00146	0.0435	CbGeAlD
Almotriptan—MAOA—blood plasma—acquired immunodeficiency syndrome	0.00143	0.0426	CbGeAlD
Almotriptan—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.00127	0.038	CbGeAlD
Almotriptan—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.00119	0.0356	CbGeAlD
Almotriptan—FMO3—vagina—acquired immunodeficiency syndrome	0.00112	0.0335	CbGeAlD
Almotriptan—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00107	0.032	CbGeAlD
Almotriptan—FMO3—lung—acquired immunodeficiency syndrome	0.00106	0.0316	CbGeAlD
Almotriptan—FMO3—nervous system—acquired immunodeficiency syndrome	0.000981	0.0293	CbGeAlD
Almotriptan—FMO3—central nervous system—acquired immunodeficiency syndrome	0.000945	0.0282	CbGeAlD
Almotriptan—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000862	0.0257	CbGeAlD
Almotriptan—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000848	0.0253	CbGeAlD
Almotriptan—MAOA—retina—acquired immunodeficiency syndrome	0.000782	0.0233	CbGeAlD
Almotriptan—FMO3—brain—acquired immunodeficiency syndrome	0.00075	0.0224	CbGeAlD
Almotriptan—FMO3—lymph node—acquired immunodeficiency syndrome	0.000725	0.0216	CbGeAlD
Almotriptan—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.000683	0.0204	CbGeAlD
Almotriptan—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000576	0.0172	CbGeAlD
Almotriptan—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000561	0.0167	CbGeAlD
Almotriptan—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000558	0.0166	CbGeAlD
Almotriptan—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000554	0.0166	CbGeAlD
Almotriptan—MAOA—digestive system—acquired immunodeficiency syndrome	0.000549	0.0164	CbGeAlD
Almotriptan—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000537	0.016	CbGeAlD
Almotriptan—CYP2C19—blood—acquired immunodeficiency syndrome	0.000534	0.0159	CbGeAlD
Almotriptan—MAOA—blood—acquired immunodeficiency syndrome	0.000523	0.0156	CbGeAlD
Almotriptan—MAOA—spinal cord—acquired immunodeficiency syndrome	0.000504	0.015	CbGeAlD
Almotriptan—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000495	0.0148	CbGeAlD
Almotriptan—MAOA—vagina—acquired immunodeficiency syndrome	0.000485	0.0145	CbGeAlD
Almotriptan—CYP2C8—blood—acquired immunodeficiency syndrome	0.000466	0.0139	CbGeAlD
Almotriptan—MAOA—lung—acquired immunodeficiency syndrome	0.000458	0.0137	CbGeAlD
Almotriptan—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000458	0.0137	CbGeAlD
Almotriptan—HTR1B—brain—acquired immunodeficiency syndrome	0.00044	0.0131	CbGeAlD
Almotriptan—CYP1A2—blood—acquired immunodeficiency syndrome	0.000436	0.013	CbGeAlD
Almotriptan—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000432	0.0129	CbGeAlD
Almotriptan—HTR1D—brain—acquired immunodeficiency syndrome	0.000426	0.0127	CbGeAlD
Almotriptan—MAOA—nervous system—acquired immunodeficiency syndrome	0.000425	0.0127	CbGeAlD
Almotriptan—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000417	0.0125	CbGeAlD
Almotriptan—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000412	0.0123	CbGeAlD
Almotriptan—MAOA—central nervous system—acquired immunodeficiency syndrome	0.000409	0.0122	CbGeAlD
Almotriptan—CYP2E1—blood—acquired immunodeficiency syndrome	0.000393	0.0117	CbGeAlD
Almotriptan—CYP1A2—lung—acquired immunodeficiency syndrome	0.000383	0.0114	CbGeAlD
Almotriptan—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000378	0.0113	CbGeAlD
Almotriptan—CYP2E1—lung—acquired immunodeficiency syndrome	0.000344	0.0103	CbGeAlD
Almotriptan—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000332	0.0099	CbGeAlD
Almotriptan—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000326	0.00974	CbGeAlD
Almotriptan—MAOA—brain—acquired immunodeficiency syndrome	0.000325	0.00969	CbGeAlD
Almotriptan—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000319	0.00951	CbGeAlD
Almotriptan—CYP3A4—blood—acquired immunodeficiency syndrome	0.000316	0.00943	CbGeAlD
Almotriptan—MAOA—lymph node—acquired immunodeficiency syndrome	0.000314	0.00936	CbGeAlD
Almotriptan—CYP2D6—blood—acquired immunodeficiency syndrome	0.000311	0.00928	CbGeAlD
Almotriptan—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000307	0.00916	CbGeAlD
Almotriptan—CYP2C8—brain—acquired immunodeficiency syndrome	0.000289	0.00864	CbGeAlD
Almotriptan—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000256	0.00765	CbGeAlD
Almotriptan—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000252	0.00753	CbGeAlD
Almotriptan—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000247	0.00737	CbGeAlD
Almotriptan—CYP2E1—brain—acquired immunodeficiency syndrome	0.000244	0.00727	CbGeAlD
Almotriptan—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000243	0.00725	CbGeAlD
Almotriptan—CYP2D6—brain—acquired immunodeficiency syndrome	0.000193	0.00576	CbGeAlD
Almotriptan—Vomiting—Didanosine—acquired immunodeficiency syndrome	0.000189	0.000838	CcSEcCtD
Almotriptan—Agitation—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000838	CcSEcCtD
Almotriptan—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000189	0.000837	CcSEcCtD
Almotriptan—Insomnia—Indinavir—acquired immunodeficiency syndrome	0.000189	0.000836	CcSEcCtD
Almotriptan—Loss of consciousness—Ritonavir—acquired immunodeficiency syndrome	0.000188	0.000832	CcSEcCtD
Almotriptan—Rash—Didanosine—acquired immunodeficiency syndrome	0.000188	0.000831	CcSEcCtD
Almotriptan—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000187	0.00083	CcSEcCtD
Almotriptan—Hypersensitivity—Abacavir—acquired immunodeficiency syndrome	0.000187	0.00083	CcSEcCtD
Almotriptan—Dermatitis—Didanosine—acquired immunodeficiency syndrome	0.000187	0.00083	CcSEcCtD
Almotriptan—Headache—Didanosine—acquired immunodeficiency syndrome	0.000186	0.000825	CcSEcCtD
Almotriptan—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000824	CcSEcCtD
Almotriptan—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000186	0.000823	CcSEcCtD
Almotriptan—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000186	0.000822	CcSEcCtD
Almotriptan—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000186	0.000822	CcSEcCtD
Almotriptan—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000186	0.000822	CcSEcCtD
Almotriptan—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000185	0.000821	CcSEcCtD
Almotriptan—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000821	CcSEcCtD
Almotriptan—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000185	0.000819	CcSEcCtD
Almotriptan—Vertigo—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000819	CcSEcCtD
Almotriptan—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000185	0.000818	CcSEcCtD
Almotriptan—Syncope—Saquinavir—acquired immunodeficiency syndrome	0.000185	0.000817	CcSEcCtD
Almotriptan—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000184	0.000816	CcSEcCtD
Almotriptan—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000184	0.000815	CcSEcCtD
Almotriptan—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000184	0.000814	CcSEcCtD
Almotriptan—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000184	0.000813	CcSEcCtD
Almotriptan—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000183	0.000812	CcSEcCtD
Almotriptan—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000183	0.000812	CcSEcCtD
Almotriptan—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000183	0.000811	CcSEcCtD
Almotriptan—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000183	0.000809	CcSEcCtD
Almotriptan—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000183	0.000809	CcSEcCtD
Almotriptan—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000182	0.000808	CcSEcCtD
Almotriptan—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000182	0.000807	CcSEcCtD
Almotriptan—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000806	CcSEcCtD
Almotriptan—Myalgia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000806	CcSEcCtD
Almotriptan—Arthralgia—Ritonavir—acquired immunodeficiency syndrome	0.000182	0.000806	CcSEcCtD
Almotriptan—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000804	CcSEcCtD
Almotriptan—Loss of consciousness—Saquinavir—acquired immunodeficiency syndrome	0.000181	0.000801	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000181	0.000801	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.00018	0.000798	CcSEcCtD
Almotriptan—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00018	0.000797	CcSEcCtD
Almotriptan—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00018	0.000797	CcSEcCtD
Almotriptan—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.000797	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Efavirenz—acquired immunodeficiency syndrome	0.00018	0.000796	CcSEcCtD
Almotriptan—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.000179	0.000795	CcSEcCtD
Almotriptan—Pain—Indinavir—acquired immunodeficiency syndrome	0.000179	0.000791	CcSEcCtD
Almotriptan—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000178	0.00079	CcSEcCtD
Almotriptan—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.00079	CcSEcCtD
Almotriptan—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000178	0.000789	CcSEcCtD
Almotriptan—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000178	0.000787	CcSEcCtD
Almotriptan—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000177	0.000786	CcSEcCtD
Almotriptan—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000177	0.000786	CcSEcCtD
Almotriptan—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000177	0.000785	CcSEcCtD
Almotriptan—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000177	0.000784	CcSEcCtD
Almotriptan—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000177	0.000784	CcSEcCtD
Almotriptan—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000177	0.000783	CcSEcCtD
Almotriptan—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000177	0.000783	CcSEcCtD
Almotriptan—Vertigo—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.000781	CcSEcCtD
Almotriptan—Syncope—Lamivudine—acquired immunodeficiency syndrome	0.000176	0.00078	CcSEcCtD
Almotriptan—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000176	0.000779	CcSEcCtD
Almotriptan—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000176	0.000779	CcSEcCtD
Almotriptan—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000175	0.000777	CcSEcCtD
Almotriptan—Myalgia—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000776	CcSEcCtD
Almotriptan—Arthralgia—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000776	CcSEcCtD
Almotriptan—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000776	CcSEcCtD
Almotriptan—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000175	0.000773	CcSEcCtD
Almotriptan—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000174	0.000771	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000174	0.000771	CcSEcCtD
Almotriptan—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000174	0.000769	CcSEcCtD
Almotriptan—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000767	CcSEcCtD
Almotriptan—Loss of consciousness—Lamivudine—acquired immunodeficiency syndrome	0.000173	0.000764	CcSEcCtD
Almotriptan—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000172	0.000762	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Delavirdine—acquired immunodeficiency syndrome	0.000172	0.000762	CcSEcCtD
Almotriptan—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000172	0.00076	CcSEcCtD
Almotriptan—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000171	0.000759	CcSEcCtD
Almotriptan—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000171	0.000759	CcSEcCtD
Almotriptan—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000171	0.000758	CcSEcCtD
Almotriptan—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000171	0.000756	CcSEcCtD
Almotriptan—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000171	0.000756	CcSEcCtD
Almotriptan—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000171	0.000756	CcSEcCtD
Almotriptan—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000754	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.000754	CcSEcCtD
Almotriptan—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.00017	0.000753	CcSEcCtD
Almotriptan—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.00017	0.000753	CcSEcCtD
Almotriptan—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00017	0.000753	CcSEcCtD
Almotriptan—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.00017	0.000751	CcSEcCtD
Almotriptan—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000169	0.000751	CcSEcCtD
Almotriptan—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000169	0.00075	CcSEcCtD
Almotriptan—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000169	0.000747	CcSEcCtD
Almotriptan—Pain—Efavirenz—acquired immunodeficiency syndrome	0.000169	0.000747	CcSEcCtD
Almotriptan—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000169	0.000747	CcSEcCtD
Almotriptan—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000169	0.000746	CcSEcCtD
Almotriptan—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000745	CcSEcCtD
Almotriptan—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000168	0.000745	CcSEcCtD
Almotriptan—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000168	0.000743	CcSEcCtD
Almotriptan—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000168	0.000742	CcSEcCtD
Almotriptan—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00074	CcSEcCtD
Almotriptan—Myalgia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00074	CcSEcCtD
Almotriptan—Arthralgia—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.00074	CcSEcCtD
Almotriptan—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.000167	0.000738	CcSEcCtD
Almotriptan—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.000166	0.000736	CcSEcCtD
Almotriptan—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000166	0.000735	CcSEcCtD
Almotriptan—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.000732	CcSEcCtD
Almotriptan—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000732	CcSEcCtD
Almotriptan—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000165	0.000731	CcSEcCtD
Almotriptan—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000165	0.000731	CcSEcCtD
Almotriptan—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000165	0.00073	CcSEcCtD
Almotriptan—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000165	0.00073	CcSEcCtD
Almotriptan—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000164	0.000727	CcSEcCtD
Almotriptan—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000164	0.000724	CcSEcCtD
Almotriptan—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000163	0.000723	CcSEcCtD
Almotriptan—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000163	0.000723	CcSEcCtD
Almotriptan—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000163	0.000723	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000722	CcSEcCtD
Almotriptan—Rash—Stavudine—acquired immunodeficiency syndrome	0.000163	0.000721	CcSEcCtD
Almotriptan—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000163	0.000721	CcSEcCtD
Almotriptan—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000163	0.000721	CcSEcCtD
Almotriptan—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000163	0.00072	CcSEcCtD
Almotriptan—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000162	0.000719	CcSEcCtD
Almotriptan—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000162	0.000719	CcSEcCtD
Almotriptan—Headache—Stavudine—acquired immunodeficiency syndrome	0.000162	0.000717	CcSEcCtD
Almotriptan—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000162	0.000716	CcSEcCtD
Almotriptan—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000162	0.000716	CcSEcCtD
Almotriptan—Pain—Delavirdine—acquired immunodeficiency syndrome	0.000161	0.000715	CcSEcCtD
Almotriptan—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000161	0.000714	CcSEcCtD
Almotriptan—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000161	0.000713	CcSEcCtD
Almotriptan—Rash—Abacavir—acquired immunodeficiency syndrome	0.00016	0.000711	CcSEcCtD
Almotriptan—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.00016	0.00071	CcSEcCtD
Almotriptan—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.00016	0.00071	CcSEcCtD
Almotriptan—Headache—Abacavir—acquired immunodeficiency syndrome	0.000159	0.000706	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Ritonavir—acquired immunodeficiency syndrome	0.000159	0.000704	CcSEcCtD
Almotriptan—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000159	0.000704	CcSEcCtD
Almotriptan—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000159	0.000703	CcSEcCtD
Almotriptan—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000158	0.000699	CcSEcCtD
Almotriptan—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000158	0.000698	CcSEcCtD
Almotriptan—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000157	0.000696	CcSEcCtD
Almotriptan—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000157	0.000694	CcSEcCtD
Almotriptan—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000691	CcSEcCtD
Almotriptan—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000156	0.000691	CcSEcCtD
Almotriptan—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000156	0.000689	CcSEcCtD
Almotriptan—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000156	0.000689	CcSEcCtD
Almotriptan—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000156	0.000689	CcSEcCtD
Almotriptan—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000155	0.000687	CcSEcCtD
Almotriptan—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000155	0.000686	CcSEcCtD
Almotriptan—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.000154	0.000684	CcSEcCtD
Almotriptan—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.000154	0.000682	CcSEcCtD
Almotriptan—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.000154	0.000681	CcSEcCtD
Almotriptan—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.000154	0.00068	CcSEcCtD
Almotriptan—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000154	0.00068	CcSEcCtD
Almotriptan—Nausea—Stavudine—acquired immunodeficiency syndrome	0.000153	0.000679	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000153	0.000678	CcSEcCtD
Almotriptan—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000152	0.000673	CcSEcCtD
Almotriptan—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000151	0.000669	CcSEcCtD
Almotriptan—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000151	0.000668	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000151	0.000667	CcSEcCtD
Almotriptan—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.00015	0.000666	CcSEcCtD
Almotriptan—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.00015	0.000663	CcSEcCtD
Almotriptan—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.00015	0.000663	CcSEcCtD
Almotriptan—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000149	0.000661	CcSEcCtD
Almotriptan—Pain—Ritonavir—acquired immunodeficiency syndrome	0.000149	0.000661	CcSEcCtD
Almotriptan—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000661	CcSEcCtD
Almotriptan—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000149	0.000661	CcSEcCtD
Almotriptan—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000148	0.000657	CcSEcCtD
Almotriptan—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000148	0.000655	CcSEcCtD
Almotriptan—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000148	0.000654	CcSEcCtD
Almotriptan—Musculoskeletal discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000146	0.000647	CcSEcCtD
Almotriptan—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000145	0.000644	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000642	CcSEcCtD
Almotriptan—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000145	0.000642	CcSEcCtD
Almotriptan—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000641	CcSEcCtD
Almotriptan—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000144	0.000637	CcSEcCtD
Almotriptan—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000637	CcSEcCtD
Almotriptan—Pain—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.000636	CcSEcCtD
Almotriptan—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000633	CcSEcCtD
Almotriptan—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000633	CcSEcCtD
Almotriptan—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000143	0.000632	CcSEcCtD
Almotriptan—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000143	0.000632	CcSEcCtD
Almotriptan—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000631	CcSEcCtD
Almotriptan—Rash—Zidovudine—acquired immunodeficiency syndrome	0.000142	0.000627	CcSEcCtD
Almotriptan—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000142	0.000627	CcSEcCtD
Almotriptan—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.000141	0.000626	CcSEcCtD
Almotriptan—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.000141	0.000625	CcSEcCtD
Almotriptan—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000141	0.000623	CcSEcCtD
Almotriptan—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00014	0.000618	CcSEcCtD
Almotriptan—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000139	0.000616	CcSEcCtD
Almotriptan—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000138	0.000613	CcSEcCtD
Almotriptan—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000613	CcSEcCtD
Almotriptan—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000612	CcSEcCtD
Almotriptan—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000138	0.000611	CcSEcCtD
Almotriptan—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000611	CcSEcCtD
Almotriptan—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000138	0.000611	CcSEcCtD
Almotriptan—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000608	CcSEcCtD
Almotriptan—Pain—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000607	CcSEcCtD
Almotriptan—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000135	0.0006	CcSEcCtD
Almotriptan—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000598	CcSEcCtD
Almotriptan—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000134	0.000591	CcSEcCtD
Almotriptan—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000133	0.000591	CcSEcCtD
Almotriptan—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000588	CcSEcCtD
Almotriptan—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000133	0.000588	CcSEcCtD
Almotriptan—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000133	0.000588	CcSEcCtD
Almotriptan—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000132	0.000585	CcSEcCtD
Almotriptan—Rash—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000583	CcSEcCtD
Almotriptan—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000132	0.000582	CcSEcCtD
Almotriptan—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000131	0.00058	CcSEcCtD
Almotriptan—Headache—Indinavir—acquired immunodeficiency syndrome	0.000131	0.000579	CcSEcCtD
Almotriptan—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.00013	0.000578	CcSEcCtD
Almotriptan—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000129	0.000572	CcSEcCtD
Almotriptan—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.000129	0.000569	CcSEcCtD
Almotriptan—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000561	CcSEcCtD
Almotriptan—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.000561	CcSEcCtD
Almotriptan—Vomiting—Efavirenz—acquired immunodeficiency syndrome	0.000125	0.000555	CcSEcCtD
Almotriptan—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000125	0.000555	CcSEcCtD
Almotriptan—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000125	0.000553	CcSEcCtD
Almotriptan—Rash—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000551	CcSEcCtD
Almotriptan—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.00055	CcSEcCtD
Almotriptan—Nausea—Indinavir—acquired immunodeficiency syndrome	0.000124	0.000549	CcSEcCtD
Almotriptan—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	0.000124	0.000548	CcSEcCtD
Almotriptan—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000124	0.000547	CcSEcCtD
Almotriptan—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000547	CcSEcCtD
Almotriptan—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000121	0.000534	CcSEcCtD
Almotriptan—Vomiting—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000531	CcSEcCtD
Almotriptan—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000119	0.000529	CcSEcCtD
Almotriptan—Rash—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000527	CcSEcCtD
Almotriptan—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	0.000119	0.000527	CcSEcCtD
Almotriptan—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000119	0.000526	CcSEcCtD
Almotriptan—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000118	0.000524	CcSEcCtD
Almotriptan—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	0.000118	0.000523	CcSEcCtD
Almotriptan—Nausea—Efavirenz—acquired immunodeficiency syndrome	0.000117	0.000519	CcSEcCtD
Almotriptan—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.000115	0.000511	CcSEcCtD
Almotriptan—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000115	0.000509	CcSEcCtD
Almotriptan—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.000509	CcSEcCtD
Almotriptan—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000502	CcSEcCtD
Almotriptan—Nausea—Delavirdine—acquired immunodeficiency syndrome	0.000112	0.000497	CcSEcCtD
Almotriptan—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000111	0.000492	CcSEcCtD
Almotriptan—Vomiting—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.000491	CcSEcCtD
Almotriptan—Rash—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000487	CcSEcCtD
Almotriptan—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	0.00011	0.000487	CcSEcCtD
Almotriptan—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000486	CcSEcCtD
Almotriptan—Headache—Ritonavir—acquired immunodeficiency syndrome	0.000109	0.000484	CcSEcCtD
Almotriptan—Vomiting—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.000473	CcSEcCtD
Almotriptan—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000106	0.000469	CcSEcCtD
Almotriptan—Rash—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000469	CcSEcCtD
Almotriptan—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	0.000106	0.000469	CcSEcCtD
Almotriptan—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000105	0.000466	CcSEcCtD
Almotriptan—Nausea—Ritonavir—acquired immunodeficiency syndrome	0.000104	0.000459	CcSEcCtD
Almotriptan—Vomiting—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000451	CcSEcCtD
Almotriptan—Rash—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000448	CcSEcCtD
Almotriptan—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	0.000101	0.000447	CcSEcCtD
Almotriptan—Headache—Lamivudine—acquired immunodeficiency syndrome	0.0001	0.000445	CcSEcCtD
Almotriptan—Nausea—Saquinavir—acquired immunodeficiency syndrome	9.98e-05	0.000442	CcSEcCtD
Almotriptan—Nausea—Lamivudine—acquired immunodeficiency syndrome	9.52e-05	0.000422	CcSEcCtD
